webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

PROTAC

PROTAC

Strengthen Your R&D With Our Services

Design of the Ligase System

Design of the Ligase System

Target Protein Services

Target Protein Services

PROTAC<sup>®</sup> Design Services

PROTAC® Design Services

PROTAC<sup>®</sup> <em>In Vitro</em> Evaluation

PROTAC® In Vitro Evaluation

PROTAC<sup>®</sup> <em>In Vivo</em> Evaluation

PROTAC® In Vivo Evaluation

Structures and Machanisms of PROTAC<sup>®</sup>

Structures and Machanisms of PROTAC®

Custom Protein Expression & Purification<sup>®</sup>

Custom Protein Expression & Purification®

Bring Innovative Products to Our Customers

E3 Ligase Ligand-Linker Conjugate

E3 Ligase Ligand-Linker Conjugate

Ligand for E3 Ligase

Ligand for E3 Ligase
Ligand for Target Protein

Ligand for Target Protein
PROTAC

PROTAC
PROTAC Linker

PROTAC Linker
SNIPER

SNIPER
>Molecular Glue

Molecular Glue
Targets

Targets
Ubiquitin Ligases

Ubiquitin Ligases

Resources

BOC Sciences is committed to providing one-stop Proteolysis Targeting Chimeric (PROTAC®), which has become a promising strategy in the field of drug discovery.

An Overview of Membrane-Associated E3 Ubiquitin Ligases

An Overview of Membrane-Associated E3 Ubiquitin Ligases

Comprehensive review of membrane E3 ubiquitin ligases in protein degradation.

Application of PROTAC in the Treatment of NSCLC

In the realm of NSCLC, common mutated targets such as KRAS, EGFR, and ALK have been effectively degraded in preclinical studies using PROTAC technology.

Application of PROTAC in the Treatment of NSCLC

BioPROTAC: A Complementary Approach of PROTAC for Protein Degradation

Discover BioPROTAC technology complementing standard PROTAC methods in drug design.

BioPROTAC: A Complementary Approach of PROTAC for Protein Degradation

Design Principles of PROTAC Delivery Systems

Key principles for designing effective PROTAC delivery platforms and formulations.

Design Principles of PROTAC Delivery Systems

Development of Deubiquitinase-targeting Chimeras (DUBTACs)

Insight into the latest advances in developing DUBTACs for disease treatment.

Development of Deubiquitinase-targeting Chimeras (DUBTACs)

Emergence of Research in Pro-PROTACs

Review of emerging studies and innovations in Pro-PROTAC therapeutics.

Emergence of Research in Pro-PROTACs

Want to join us?

At BOC Sciences, you will work with people who are enthusiastic and passionate about science and technology.
Join our team and build your career with us!

For More Positions

About Us

As a leading service provider in drug discovery and research, BOC Sciences is fully capable and committed to
providing one-stop Proteolysis Targeting Chimeric (PROTAC®) services to customers around the world to meet new drug discovery goals.

Professional Teams

Professional Teams

Standard Workflow

Standard Workflow

Advancded Facilities

Advancded Facilities

Rich Experience

Rich Experience

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2025 BOC Sciences. All Rights Reserved.
Inquiry Basket
Loading ......
Delete selectedGo to checkout